ALSO READOrchid Pharma gets EIR from USFDA for its Chennai facility Orchid Pharma drops after bulk deal Orchid Pharma gets EIR from USFDA for its Alathur facility Orchid Pharma receives EIR report for API facility in Alathur, Tamil Nadu Orchid Pharma advances after USFDA nod for antipsychotic tablets
By USFDAOrchid Pharma has received the Establishment Inspection Report from USFDA based on the successful inspection closure for the Post-marketing Adverse Drug Experience reporting Inspection (PADE) conducted at Orchid Tower 313, Valluvar Kottam High Road, Nungambakkam, Chennai.
The facility was inspected by USFDA in the month of June 2017.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)